Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News United Therapeutics Corp UTHR

Healthcare Biotechnology
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:UTHR)

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

Business Wire November 5, 2024

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

Business Wire October 30, 2024

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

Business Wire October 23, 2024

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

Business Wire October 23, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

Business Wire September 24, 2024

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind-Ever

Business Wire September 10, 2024

United Therapeutics Corporation to Present at Upcoming Investor Conferences

Business Wire August 28, 2024

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

Business Wire July 31, 2024

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

Business Wire July 24, 2024
View More News ››

Opinion & Analysis (NDAQ:UTHR)

Capitalizing on the "V-Bottom" with UTHR

Benzinga.com  October 21, 2014
View More Opinion ››

Bullboard Posts (NDAQ:UTHR)

United Therapeutics Corporation to Present at Upcoming Inves

JUST IN: $UTHR United Therapeutics Corporation to Present at Upcoming Investor ConferencesUnited Therapeutics Corporation (Nasdaq: UTHR ...
whytestocks - August 28, 2024

United Therapeutics Corp (NASDAQ:UTHR): A Specialized Biotec

http://beyondspx.com/2024/08/01/united-therapeutics-corp-nasdaquthr-a-specialized-biotech-powerhouse-delivering-consistent-growth/
MikeTester - August 2, 2024

United Therapeutics Corporation Reports Second Quarter 2024

Just In: $UTHR United Therapeutics Corporation Reports Second Quarter 2024 Financial ResultsUnited Therapeutics Corporation (Nasdaq...
whytestocks - July 31, 2024

BUY BUY BUY BUY BUY

With MIRO AQUISITION THIS THING SET TO FLY
Nibinator - October 30, 2023

Real stock price share value

148$
Nibinator - October 30, 2023

Insider Buying

http://www.gurufocus.com/news.php?id=58696
videomart - June 21, 2009
View more Bullboard ››

Eminent Gold Corp.

Eminent Gold Corp.

Eminent Gold Corp. is a gold exploration company focused on the exploration and discovery of gold deposits in Nevada. The ...
View More »